TrialJournal of clinical lipidology

Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .

Charlton Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.